There are several errors in this article.

In the abstract and the Introduction section, the term "chemoembolization" should be "embolization".

Throughout the article, including [Figure 1](#pone-0103921-g001){ref-type="fig"}, the abbreviation \"TACE\" should be \"TAE\", with the exception of the second sentence in the sixth paragraph of the Results section, row fifteen of [Table 4](#pone-0103921-t001){ref-type="table"}, and the figure legend of Figure 3c.

![Treatment algorithm for spontaneous rupture of HCCs.](pone.0103921.g001){#pone-0103921-g001}

The correct version of the second sentence in the sixth paragraph of the Results section is: Sixteen patients in period 1 and 19 patients in period 2 received transarterial chemoembolization as a cancer treatment.

The correct version of [Table 4](#pone-0103921-t001){ref-type="table"} can be viewed below. The figure legend for Figure 3c is correct as is published.
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###### Factors that might affect patient survival.

![](pone.0103921.t001){#pone-0103921-t001-1}

                                    1991-2000   2001-2010   1991-2010                                         
  -------------------------------- ----------- ----------- ----------- ----- ------- ---------- ----- ------- ----------
  Tumor size (cm)                                             0.003                    0.001                   \<0.0001
  ≤10                                  31         4.63                  62    5.06               93    5.06   
  \>10                                 34         1.25                  56    1.41               90    1.35   
  Hemostasis by RFA                                            \-                      0.089                    0.083
  No                                   70         1.61                  100   3.16               170   2.10   
  Yes                                   0          \-                   19    6.61               19    6.61   
  Hemostasis by surgery                                       0.588                    0.870                    0.653
  No                                   52         1.84                  106   3.68               158   2.33   
  Yes                                  18         0.59                  13    3.88               31    3.29   
  Hemostasis by TAE                                           0.003                    0.133                    0.001
  No                                   44         1.08                  70    2.89               114   1.71   
  Yes                                  26         6.54                  49    4.86               75    5.06   
  Subsequent TACE                                             0.068                    0.517                    0.120
  Yes                                  16         4.63                  19    5.16               35    5.16   
  No                                   54         1.05                  100   3.02               154   1.61   
  Subsequent surgery                                          0.001                   \<0.0001                 \<0.0001
  Yes                                  12         16.69                 16    17.12              28    19.45  
  No                                   58         1.22                  103   2.56               161   1.61   
  Shock on presentation                                       0.097                    0.149                     0.96
  No                                   37         2.14                  68    3.68               105   3.02   
  Yes                                  33         0.59                  51    4.83               84    1.38   
  Child-Pugh class                                          \<0.0001                   0.197                   \<0.0001
  A                                    30         8.18                  55    4.86               85    5.75   
  B                                    26         0.79                  48    2.76               74    1.25   
  C                                     9         0.36                  16    0.62               25    0.62   
  MELD score                                                 0.0004                    0.399                    0.123
  ≤11                                  28         7.76                  61    3.85               89    4.04   
  \>11                                 33         1.22                  57    2.76               90    1.31   
  Total bilirubin (umol/L)                                   0.0002                    0.001                   \<0.0001
  ≤19                                  32         6.54                  62    5.52               94    5.75   
  \>19                                 36         1.05                  57    1.35               93    1.22   
  Platelet (×10^9^/L)                                         0.679                    0.168                    0.449
  ≤192.5                               41         1.35                  53    5.06               94    3.85   
  \>192.5                              27         1.94                  66    2.56               93    2.17   
  International normalized ratio                              0.001                    0.621                    0.019
  ≤1.2                                 37         2.53                  77    4.47               114   4.04   
  \>1.2                                25         0.89                  41    1.51               66    1.22   
  Albumin (g/L)                                               0.063                    0.443                    0.086
  ≤34                                  35         1.08                  67    2.89               102   1.31   
  \>34                                 33         4.63                  52    4.24               85    4.47   

TACE, transarterial chemoembolization

MELD score, Model for End-stage Liver Disease score (to the nearest integer of the median)

The authors have provided corrected version of [Figure 1](#pone-0103921-g001){ref-type="fig"} and [Table 4](#pone-0103921-t001){ref-type="table"}, which can be viewed here.
